|
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning Clinical research trials and Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning. Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning clinical trial. Human subjects often get the best healthcare possible for their Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning  Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
For Condition: Anxiety Disorders
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to increase researchers' understanding of the biological basis of generalized anxiety disorder and social anxiety disorder. They will investigate how the brain activity associated with specific thoughts and feelings may play a role in these anxiety disorders. This knowledge will be used to design interventions to help those with these illnesses. To qualify for this study, participants must be evaluated via an initial telephone screening interview and material sent through the mail. Participants will then be required to make three visits to NIH. During the first visit, they will be asked questions about their general mood, degree of nervousness, thinking skills, and behavior. They will undergo a thorough physical exam, including an EKG, blood work, urinalysis, and a pregnancy test for women of childbearing potential. During the second visit, participants will spend about 2.5 hours doing various tasks while sitting and looking at a computer screen. These tasks will guide them to experience specific kinds of thoughts and emotions. Researchers will attach electrodes to the participants' hands to monitor the amount of electricity conducted by the skin. The third visit will be similar to the second visit, but participants will perform the tasks while lying in a MRI scanner. Participants will be compensated up to $400 for their involvement in this study.
Details: There have been suggestions that the threshold for amygdala activity is lower in individuals with anxiety disorders than in healthy individuals. However, despite its immediate plausibility, there have been relatively few tests of this hypothesis. Specifically, there have been very few explorations of the performance of patients with anxiety disorders on measures known to implicate the amygdala. Although the high co-morbidity of Generalized Anxiety Disorder (GAD) and Social Anxiety Disorder (SAD) complicates the issue, the fact that the disorders doubly dissociate suggests that they are due to dysfunctional activity in separable neurocognitive systems. We would suggest that the hyper-responsive amygdala hypothesis is more likely to be linked to the explanation of GAD. In contrast, SAD may be due to reduced activation thresholds for units in a system that responds to social threat and which recruits lateral orbital frontal cortex. Thus, the current project will determine the performance of patients with GAD and SAD on measures in which the amygdala is known to play a role and also ib measures that recruit lateral orbital frontal cortex and the system for social response reversal. In addition, two proposed neuro-imaging studies will directly assess neural responses in these two systems in both patient populations. The project should provide clear data that will inform future theorizing on the pathology implicated in these two disorders.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age: Participants will be males and females, 20-65 years of age. IQ: IQ, as measured by 4 subscales from the Wechsler Adult Intelligence Scale-Revised (WAIS-R), must be greater than 80. Medication status: No regular use of psychotropic medication within 2 weeks of the study (or fluoxetine within 8 weeks of the study). No regular use of any benzodiazepine. We intend to identify patients whose GAD/SAD is currently untreated. EXCLUSION CRITERIA: Because factors such as psychiatric disease, or CNS disease, can influence functional brain activity, and pregnancy precludes participation in fMRI studies, these factors are exclusionary. (1) Psychiatric history: Participants will be assessed using DSM-IV criteria via standardized psychiatric interviews conducted by trained examiners (i.e., SCID). Any current suicidal ideation will be exclusionary. a. Healthy comparison individuals (Group 1): All participants will be free of any current psychiatric disorder as well as lifetime history of psychosis, pervasive developmental disorder, major affective disorder, panic disorder, obsessive compulsive disorder, ADHD, anorexia. b. Patients with GAD (Group 2): Any history of an axis I diagnosis including SAD but not including adjustment disorder, simple phobia or dysthymia is exclusionary. There must be no current mood disorder (MD) though patients with past MD, which occurred after the onset of GAD, will be admitted to the study. c. Patients with SAD (Group 3): Any current history of an axis I diagnosis apart from GAD and mood disorder (MD) but not including adjustment disorder, simple phobia or dysthymia is exclusionary. Participants will be excluded if the patient's MD preceded their SAD. We recognize the difficulty of recruiting patients with SAD without co-morbid GAD and will therefore allow patients who are comorbid into the study in this group. (2) History of Substance Dependence: A history of Axis I substance dependence (including alcohol dependence) will be exclusionary. A history of substance abuse diagnosis will not be exclusionary. (3) Severe acute and chronic medical illnesses. (4) CNS disease: history of brain abnormalities (e.g., neoplasms, subarachnoid cysts), cerebrovascular disease, infectious disease (e.g., abscess), or other neurological disease, or history of head trauma (defined as a loss of consciousness greater than 3 min). (5) Metal or electronic objects: Metal plates, certain types of dental braces, cardiac pacemakers, etc., that are sensitive to electromagnetic fields contraindicate MRI scans. (6) Claustrophobia: participants will be questioned about potential discomfort in being in an enclosed space, such as an MRI scanner. (7) Pregnancy status: Because of the potential effects of hormonal changes on brain function as well as the unknown effects of electromagnetic field on the fetus, known pregnancy is an exclusion criterion.
Total Enrollment: 60
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 030185; 03-M-0185
Study Start Date: June 5, 2003
Record last reviewed: March 9, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00062517
Other Anxiety Disorders Studies:
1. MRI Study of Brain Activity and Risk for Depression in Adolescents
2. Child and Adolescent Anxiety Disorders (CAMS)
3. Reward-Related Processes and Brain Function
4. The Psychobiology of Childhood Temperament
5. Cognitive and Drug Therapy for Drug-Resistant Depression
Related Studies:
Other Anxiety Disorders Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
|
|
|
|
|
|
|
|
